US Stock MarketDetailed Quotes
PHIO Phio Pharmaceuticals
- 3.2900
- +0.3900+13.45%
Close Sep 13 16:00 ET
- 3.2900
- 0.00000.00%
Post 20:01 ET
2.83MMarket Cap-203P/E (TTM)
3.4683High2.8735Low112.89KVolume2.8750Open2.9000Pre Close355.87KTurnover20.61%Turnover RatioLossP/E (Static)860.72KShares29.070052wk High0.75P/B1.80MFloat Cap2.400052wk Low--Dividend TTM547.83KShs Float3118.4994Historical High--Div YieldTTM20.51%Amplitude2.4000Historical Low3.1520Avg Price1Lot Size
About Phio Pharmaceuticals Company
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
Company Profile
SymbolPHIO
Company NamePhio Pharmaceuticals
Listing DateFeb 11, 2014
Founded2011
CEOMr. Robert J. Bitterman
MarketNASDAQ
Employees9
Fiscal Year Ends12-31
Address11 Apex Drive,Suite 300A PMB 2006
CityMarlborough
ProvinceMassachusetts
CountryUnited States of America
Zip Code01752
Phone1-508-767-3861
Websitehttp://www.phiopharma.com
Company Executives
- Name
- Position
- Salary
- Robert J. Bitterman
- Chairman of the Board, Chief Executive Officer and President
- 437.89K
- Robert M. Infarinato
- Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Caitlin Kontulis
- Principal Accounting Officer, Vice President, Finance and Administration and Secretary
- --
- Robert L. Ferrara
- Lead Independent Director
- 70.36K
- Dr. Jonathan E. Freeman, PhD
- Independent Director
- 42.86K
- Patricia A. Bradford
- Independent Director
- 57.86K
- Dr. Curtis A. Lockshin, PhD
- Independent Director
- 50.36K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
